Methadone Clinics in cities of Alabama
Medication Treatment for Opioid Use Disorder, including Methadone in Alabama
Alabama spent years near the top of the country for opioid prescribing, and that history shapes where treatment is and is not available. Although methadone in Alabama is a popular choice, the state treats opioid use disorder (OUD) with three FDA-approved medications: methadone, buprenorphine, and naltrexone, offered through opioid treatment programs (OTPs) and through doctors’ offices that prescribe in an office-based setting.
Coverage for these treatments is uneven across the state. The metro areas around Birmingham, Huntsville, Mobile, and Montgomery are where most of the clinics are located, while many rural counties rely on office-based prescribers and telehealth. The listings on this page show providers by city, and the statewide helpline can point you to the nearest option.
The Three Medications and the Two Places You Can Get Them
Choosing medication-assisted treatment, including methadone in Alabama, comes down to two questions: which medication, and what setting. Each of these medications works differently, and a clinician can help you decide which fits your situation.
Methadone, a long-acting medication that prevents withdrawal and cravings, is dispensed for OUD only through a licensed opioid treatment program, not a regular pharmacy. Early treatment usually means daily visits to the program.
Buprenorphine, including Suboxone and other buprenorphine-naloxone products, can be prescribed in a doctor’s office and filled at a pharmacy, or provided through a clinic; an extended-release monthly injection (Sublocade) is also available.
Naltrexone, including the monthly Vivitrol injection, can be prescribed by any licensed provider. However, treatment starts only after you have been off opioids for a set time, so a clinician plans the timing.
The setting matters as much as the medication. An opioid treatment program is a structured, daily-or-take-home option and the only place to get methadone in Alabama. Office-based opioid treatment (OBOT) means a clinician prescribes buprenorphine or naltrexone in a regular medical office.
Since 2023, any provider with a standard DEA registration can prescribe buprenorphine, which has widened availability, a real advantage in Alabama’s rural counties. To weigh the daily-clinic option against office-based care, see how methadone and Suboxone compare and our overview of methadone treatment.
Alabama Medicaid, Telehealth, and the Rules That Govern Access
Alabama Medicaid covers all three medications for opioid use disorder, and the agency has spent the past two years increasing access. Its Medications for Opioid Use Disorder (MOUD) initiative moved opioid-dependence drugs into an Electronic Prior Authorization system in January 2025, then, under Phase II effective May 12, 2025, let people new to buprenorphine fill up to a 34-day supply of a preferred medication at the pharmacy counter without manual prior authorization.
Generic buprenorphine-naloxone tablets are on the preferred list. The brand-name Suboxone became non-preferred as of July 2025, so a prescriber may need to request it. Methadone in Alabama for OUD is tied to opioid treatment programs, consistent with federal law.
Federal rules updated in 2024 expanded take-home methadone, up to a 28-day supply for patients a program judges stable, and allowed treatment to start by telehealth. As of mid-2026, buprenorphine can be started through telehealth visits, including by phone in many cases, without a prior in-person visit.
Those flexibilities run through the end of 2026 and are still being finalized, so confirm current options with your provider. Naloxone is accessible statewide without a personal prescription. Under a 2016 standing order from the State Health Officer, Alabama pharmacists can dispense it directly, and a 2022 Good Samaritan law shields people who use it in good faith during an overdose.
For why staying on a steady dose matters once you start, see keeping your methadone dose consistent, and if privacy at work is a concern, what employers can and cannot ask.
What Alabama’s Overdose Numbers Show Right Now
The trend in Alabama has turned. The state recorded a 30% decrease in substance-related overdose deaths from April 2024 to April 2025, the first notable decline since 2017. This was based on provisional CDC data reported by the Alabama Opioid Overdose and Addiction Council.
Fentanyl and other synthetic opioids remain the most common drugs in fatal overdoses, and contaminants like xylazine have complicated the drug supply, so the picture is improving rather than solved. Officials credit wider naloxone distribution, expanded treatment, and prevention work for much of the change.
The practical takeaway is that effective medication treatment exists across the state and works: the providers in the listings below, plus the helpline, are the next step. For background on how opioids affect the body and why medication helps, see our guide to opioid addiction.
Starting Treatment and Finding a Clinic Near You
Getting started usually begins with an intake assessment, where a clinician reviews your history, your goals, and your medical needs, then helps you choose a medication.
Some Alabama programs can begin treatment the same day or the same week, and some can begin buprenorphine by a telehealth visit. If you are coming off fentanyl, starting buprenorphine too soon can trigger sudden, severe withdrawal (precipitated withdrawal). Your clinician must determine the time of the first dose with you, based on your last dose of the drug. This is something to plan, not to fear.
For people who need a higher level of care than an outpatient clinic can provide, residential options are also available. Read more about starting opioid use disorder treatment and about inpatient opioid addiction treatment if a more intensive setting fits. To find a provider, use the city listings on this page or call the helpline for help locating the nearest one.
Pregnancy, Parenting, and Treatment in Alabama
Medication for opioid use disorder is the recommended standard of care for pregnant women. Stopping suddenly can be more dangerous to a pregnancy than continuing treatment. Methadone and buprenorphine are both used during pregnancy, and a care team manages neonatal opioid withdrawal syndrome (NOWS) if it occurs.
Alabama Medicaid covers OUD services for pregnant members and coordinates maternity care through the Alabama Coordinated Health Network (ACHN), which connects pregnant women with nurses and social workers. Postpartum Medicaid coverage now extends for a full year after the end of pregnancy.
Fear of child-welfare involvement keeps some people from seeking care, but treatment is the protective step, and providers experienced in perinatal care can talk you through what to expect. Loved ones helping someone decide will find methadone and pregnancy and information for families useful starting points.
Common Questions About Treatment in Alabama
Does Alabama Medicaid pay for Suboxone and methadone in Alabama?
Yes, Alabama Medicaid covers methadone, buprenorphine (including Suboxone), and naltrexone for opioid use disorder. Recent changes allow people new to buprenorphine to fill a preferred product at the pharmacy without manual prior authorization in many cases. Coverage details and preferred products can change, so confirm with the provider and your plan.
Do I have to go to a clinic every day?
Not necessarily. Methadone in Alabama usually starts with daily visits, but federal rules updated in 2024 allow take-home methadone, up to a 28-day supply for patients a program judges stable. Buprenorphine and naltrexone are prescribed in an office and filled at a pharmacy, which does not require daily visits.
Can I start treatment by telehealth in Alabama?
Often, yes for buprenorphine. As of 2026, buprenorphine can be started through telehealth, including by phone in many cases, without a prior in-person visit; these rules run through the end of 2026. Methadone for OUD is dispensed through an opioid treatment program, though some programs can begin treatment with a telehealth visit.
What is the difference between methadone and Suboxone?
Both reduce withdrawal and cravings, but methadone is dispensed only through an opioid treatment program. At the same time, buprenorphine-naloxone (Suboxone) can be prescribed in a doctor’s office and filled at a pharmacy. A fuller comparison is in our questions and answers, and you can read about whether methadone itself is addictive.
Is treatment confidential if I have a job or am on probation?
Medical treatment records are protected, and many people in treatment work or meet court requirements while in care. Programs can often provide documentation when a court or probation officer requires it. Ask the provider directly what they can verify.
Page details and disclosures
Last reviewed June 2026.
Sources:
- Alabama Opioid Overdose and Addiction Council, 2025 Annual Report (2025). https://mh.alabama.gov/wp-content/uploads/2026/01/Alabama-Opioid-Overdose-and-Addiction-Council-Report-2025.pdf
- Alabama Department of Mental Health, Understanding the Opioid Crisis (2025). https://mh.alabama.gov/understanding-the-opioid-crisis/
- Alabama Medicaid Agency, Medications for Opioid Use Disorder (MOUD) initiative and preferred drug list alerts (2025). https://medicaid.alabama.gov/documents/1.0_ALERTS/1.0_2025/1.0_ALERT_PDL_Quarterly_6-16-25.pdf
- Alabama Department of Public Health, naloxone standing order and overdose data. https://mh.alabama.gov/wp-content/uploads/2026/01/Alabama-Opioid-Overdose-and-Addiction-Council-Report-2025.pdf
- SAMHSA and DEA, federal MOUD regulations, including the 2024 revision of 42 CFR Part 8 and 2025 to 2026 telemedicine rules. https://www.samhsa.gov/substance-use/treatment/opioid-treatment-program/42-cfr-part-8
- U.S. Government Accountability Office, Medicaid OUD services for pregnant and postpartum women (GAO-20-40). https://www.gao.gov/products/gao-20-40
MethadoneCenters.com is a referrer service that provides information about addiction treatment practitioners and facilities. MethadoneCenters.com is not a medical provider or treatment facility and does not provide medical advice. The information provided is not a substitute for professional treatment advice.
Calls to any general helpline may be answered or returned by a paid advertiser. We do not receive any commission or fee that is dependent upon which treatment provider a caller chooses. There is no obligation to enter treatment.